Bank of New York Mellon’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.1M | Buy |
291,791
+35,191
| +14% | +$253K | ﹤0.01% | 2708 |
|
|
2025
Q1 | $1.54M | Sell |
256,600
-2,166
| -0.8% | -$13K | ﹤0.01% | 2797 |
|
|
2024
Q4 | $2.02M | Sell |
258,766
-4,812
| -2% | -$37.5K | ﹤0.01% | 2747 |
|
|
2024
Q3 | $2.85M | Sell |
263,578
-63,006
| -19% | -$680K | ﹤0.01% | 2581 |
|
|
2024
Q2 | $2.75M | Buy |
326,584
+45,770
| +16% | +$386K | ﹤0.01% | 2617 |
|
|
2024
Q1 | $1.89M | Sell |
280,814
-20,085
| -7% | -$135K | ﹤0.01% | 2790 |
|
|
2023
Q4 | $1.77M | Buy |
300,899
+12,692
| +4% | +$74.6K | ﹤0.01% | 2893 |
|
|
2023
Q3 | $2.81M | Buy |
288,207
+39,491
| +16% | +$385K | ﹤0.01% | 2612 |
|
|
2023
Q2 | $2.94M | Buy |
248,716
+28,822
| +13% | +$341K | ﹤0.01% | 2619 |
|
|
2023
Q1 | $2.37M | Sell |
219,894
-38,879
| -15% | -$420K | ﹤0.01% | 2704 |
|
|
2022
Q4 | $2.99M | Buy |
258,773
+4,946
| +2% | +$57.2K | ﹤0.01% | 2623 |
|
|
2022
Q3 | $3.79M | Buy |
+253,827
| New | +$3.79M | ﹤0.01% | 2447 |
|
|
2019
Q2 | – | Sell |
-13,251
| Closed | -$232K | – | 4214 |
|
|
2019
Q1 | $232K | Buy |
13,251
+1,689
| +15% | +$29.6K | ﹤0.01% | 3826 |
|
|
2018
Q4 | $204K | Buy |
11,562
+8,273
| +252% | +$146K | ﹤0.01% | 3841 |
|
|
2018
Q3 | $135K | Buy |
3,289
+213
| +7% | +$8.74K | ﹤0.01% | 3984 |
|
|
2018
Q2 | $177K | Buy |
+3,076
| New | +$177K | ﹤0.01% | 3923 |
|